6.
Mo J, Tan K, Dong Y, Lu W, Liu F, Mei Y
. Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex. Oncogene. 2022; 42(1):11-25.
DOI: 10.1038/s41388-022-02533-1.
View
7.
Sribudiani Y, Chauhan R, Alves M, Petrova L, Brosens E, Harrison C
. Identification of Variants in RET and IHH Pathway Members in a Large Family With History of Hirschsprung Disease. Gastroenterology. 2018; 155(1):118-129.e6.
DOI: 10.1053/j.gastro.2018.03.034.
View
8.
Kwon Y, Ciechanover A
. The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy. Trends Biochem Sci. 2017; 42(11):873-886.
DOI: 10.1016/j.tibs.2017.09.002.
View
9.
Bishop J, Thaper D, Zoubeidi A
. The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer. Cancers (Basel). 2014; 6(2):829-59.
PMC: 4074806.
DOI: 10.3390/cancers6020829.
View
10.
Tan K, Wu W, Zhu K, Lu L, Lv Z
. Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5. J Cancer. 2022; 13(7):2105-2125.
PMC: 9066222.
DOI: 10.7150/jca.69408.
View
11.
Huang T, Hou Y, Wang X, Wang L, Yi C, Wang C
. Direct Interaction of Sox10 With Cadherin-19 Mediates Early Sacral Neural Crest Cell Migration: Implications for Enteric Nervous System Development Defects. Gastroenterology. 2021; 162(1):179-192.e11.
DOI: 10.1053/j.gastro.2021.08.029.
View
12.
Plaza-Menacho I, van der Sluis T, Hollema H, Gimm O, Buys C, Magee A
. Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation. J Biol Chem. 2007; 282(9):6415-24.
DOI: 10.1074/jbc.M608952200.
View
13.
Fantauzzo K, Soriano P
. Receptor tyrosine kinase signaling: regulating neural crest development one phosphate at a time. Curr Top Dev Biol. 2015; 111:135-82.
PMC: 4363133.
DOI: 10.1016/bs.ctdb.2014.11.005.
View
14.
Le T, Galmiche L, Levy J, Suwannarat P, Hellebrekers D, Morarach K
. Dysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans. J Clin Invest. 2021; 131(6).
PMC: 7954599.
DOI: 10.1172/JCI145837.
View
15.
Machado R, de Andrade R, Pego S, Krepischi A, Coletta R, Martelli-Junior H
. New evidence of genetic heterogeneity causing hereditary gingival fibromatosis and ALK and CD36 as new candidate genes. J Periodontol. 2022; 94(1):108-118.
DOI: 10.1002/JPER.22-0219.
View
16.
Mendelson A, Frenette P
. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat Med. 2014; 20(8):833-46.
PMC: 4459580.
DOI: 10.1038/nm.3647.
View
17.
Ikawa H, Masuyama H, Hirabayashi T, Endo M, Yokoyama J
. More than 10 years' follow-up to total colonic aganglionosis--severe iron deficiency anemia and growth retardation. J Pediatr Surg. 1997; 32(1):25-7.
DOI: 10.1016/s0022-3468(97)90085-3.
View
18.
Coskun S, Karadag M, Gokcen C, Oztuzcu S
. miR-132 and miR-942 Expression Levels in Children with Attention Deficit and Hyperactivity Disorder: A Controlled Study. Clin Psychopharmacol Neurosci. 2021; 19(2):262-268.
PMC: 8077053.
DOI: 10.9758/cpn.2021.19.2.262.
View
19.
Sunardi M, Ito K, Sato Y, Uesaka T, Iwasaki M, Enomoto H
. A Single RET Mutation in Hirschsprung Disease Induces Intestinal Aganglionosis Via a Dominant-Negative Mechanism. Cell Mol Gastroenterol Hepatol. 2022; 15(6):1505-1524.
PMC: 10242352.
DOI: 10.1016/j.jcmgh.2022.12.003.
View
20.
SWENSON O, NEUHAUSER E, PICKETT L
. New concepts of the etiology, diagnosis and treatment of congenital megacolon (Hirschsprung's disease). Pediatrics. 1949; 4(2):201-9.
View